Morgan Stanley Maintains Overweight on NICE, Lowers Price Target to $130
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $148 to $130.
Morgan Stanley analyst Hamza Fodderwala maintains NICE (NASDAQ:NICE) with a Overweight and lowers the price target from $148 to $130.